Dr John Melki – CEO and Director – Genetic Signatures (ASX:GSS) is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
Copyright 2023 – Finance News Network
27 Aug 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes provides an update on sales and distribution for the company's Automated Plate Assessment System (APAS), which is used to read culture plates in laboratories.
10 Mar 2020 - Prospect Resources Limited (ASX:PSC) Managing Director, Sam Hosack, provides an update on the company's key lithium petalite project in Zimbabwe.
02 Jun 2023 - Falcon Metals Limited (ASX:FAL) Managing Director Tim Markwell discusses progress with the company's gold exploration, touching on key prospects and the results timeline.
08 Aug 2023 - WT Financial Group Limited (ASX:WTL) Managing Director Keith Cullen discusses drivers of profitability, the effect of lower adviser numbers in the industry and opportunities moving forward.
20 Mar 2023 - Tony Brinker, Institutional Equity Research, Select Equities, discusses what happened with the Silicon Valley Bank, and implications for Australian investors.
03 Dec 2020 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the market's record November month, expectations for 2021 and portfolio structuring.
02 Oct 2019 - Noxopharm Limited (ASX:NOX) Founder and Executive Chairman, Dr Graham Kelly, discusses early results on the use of Noxopharm's lead drug candidate, Veyonda, for the treatment of prostate cancer.